Losartan potassium Tablets, 50 mg

Product NDC: 71335-1817
Requested package NDC: 71335-1817-3
11-digit product format: 713351817
Labeler code: 71335
Product ID: 71335-1817_fb077532-f94e-44e1-afd3-6be55c4062c8
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: losartan potassium
Dosage form: TABLET
Route: ORAL
Labeler: Bryant Ranch Prepack
Application: ANDA201170
Marketing category: ANDA
Marketing start: 2012-09-18
Substance: LOSARTAN POTASSIUM
Active strength: 50 mg/1
Pharmacologic classes: Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 14 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	`1332a3947898…`	`d4bfe170f9cd…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A201170-001	LOSARTAN POTASSIUM	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	AB	2012-09-18
A201170-002	LOSARTAN POTASSIUM	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	AB	2012-09-18
A201170-003	LOSARTAN POTASSIUM	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	AB	2012-09-18

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A201170-001	AB
A201170-002	AB
A201170-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A201170-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	AB	2012-09-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A201170-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	AB	2012-09-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A201170-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	AB	2012-09-18	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A201170-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	AB	2012-09-18	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A201170-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	AB	2012-09-18	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A201170-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	AB	2012-09-18	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A201170-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	AB	2012-09-18	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A201170-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	AB	2012-09-18	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A201170-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	AB	2012-09-18	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A201170-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	AB	2012-09-18	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A201170-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	AB	2012-09-18	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A201170-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	AB	2012-09-18	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A201170-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	AB	2012-09-18	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A201170-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	AB	2012-09-18	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A201170-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	AB	2012-09-18	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A201170-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	AB	2012-09-18	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A201170-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	AB	2012-09-18	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A201170-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	AB	2012-09-18	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A201170-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	AB	2012-09-18	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A201170-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	AB	2012-09-18	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A201170-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	AB	2012-09-18	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A201170-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	AB	2012-09-18	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A201170-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	AB	2012-09-18	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A201170-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	AB	2012-09-18	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A201170-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	AB	2012-09-18	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A201170-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	AB	2012-09-18	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A201170-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	AB	2012-09-18	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A201170-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	AB	2012-09-18	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A201170-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	AB	2012-09-18	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A201170-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	AB	2012-09-18	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A201170-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	AB	2012-09-18	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A201170-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	AB	2012-09-18	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A201170-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	AB	2012-09-18	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A201170-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	AB	2012-09-18	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A201170-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	AB	2012-09-18	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A201170-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	AB	2012-09-18	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A201170-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	AB	2012-09-18	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A201170-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	AB	2012-09-18	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A201170-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	AB	2012-09-18	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A201170-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	AB	2012-09-18	`8072bd15b7f6…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A201170-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A201170-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A201170-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A201170-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A201170-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A201170-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A201170-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A201170-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A201170-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A201170-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A201170-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A201170-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A201170-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A201170-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A201170-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A201170-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A201170-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A201170-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A201170-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A201170-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A201170-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A201170-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A201170-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A201170-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A201170-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A201170-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A201170-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A201170-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A201170-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A201170-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A201170-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A201170-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A201170-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A201170-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A201170-002	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A201170-003	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A201170-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A201170-002	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A201170-003	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A201170-001	AB	1	`8072bd15b7f6…`

Additional Listing Data#

Finished product: Yes
Brand name base: Losartan potassium Tablets, 50 mg
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
LOSARTAN POTASSIUM	50 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
3ST302B24A	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
979492	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
3d7ddcac-508d-459c-96c8-c62f9c0b5193	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
0d341e63-aee5-498b-bf9a-b53a43963acf	Product name	1	20260105
de29c5c0-90ba-29da-d7ab-0500274708be	Product name	6	20241009
351abe41-466c-4dd8-840a-0fdb68318bd5	Product name	1	20230316
15b375b1-89c7-9594-80df-5a8c8864aee0	Product name	3	20180108

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
71335-1817-1	2025-10-02	These highlights do not include all the information needed to use LOSARTAN POTASSIUM TABLETS safely and effectively. See full prescribing information for LOSARTAN POTASSIUM TABLETS. LOSARTAN POTASSIUM tablets USP, for oral use Rx Only Initial U.S. Approval: 1995
71335-1817-2	2025-10-02	These highlights do not include all the information needed to use LOSARTAN POTASSIUM TABLETS safely and effectively. See full prescribing information for LOSARTAN POTASSIUM TABLETS. LOSARTAN POTASSIUM tablets USP, for oral use Rx Only Initial U.S. Approval: 1995
71335-1817-3	2025-10-02	These highlights do not include all the information needed to use LOSARTAN POTASSIUM TABLETS safely and effectively. See full prescribing information for LOSARTAN POTASSIUM TABLETS. LOSARTAN POTASSIUM tablets USP, for oral use Rx Only Initial U.S. Approval: 1995
71335-1817-4	2025-10-02	These highlights do not include all the information needed to use LOSARTAN POTASSIUM TABLETS safely and effectively. See full prescribing information for LOSARTAN POTASSIUM TABLETS. LOSARTAN POTASSIUM tablets USP, for oral use Rx Only Initial U.S. Approval: 1995
71335-1817-5	2025-10-02	These highlights do not include all the information needed to use LOSARTAN POTASSIUM TABLETS safely and effectively. See full prescribing information for LOSARTAN POTASSIUM TABLETS. LOSARTAN POTASSIUM tablets USP, for oral use Rx Only Initial U.S. Approval: 1995
71335-1817-6	2025-10-02	These highlights do not include all the information needed to use LOSARTAN POTASSIUM TABLETS safely and effectively. See full prescribing information for LOSARTAN POTASSIUM TABLETS. LOSARTAN POTASSIUM tablets USP, for oral use Rx Only Initial U.S. Approval: 1995
71335-1817-7	2025-10-02	These highlights do not include all the information needed to use LOSARTAN POTASSIUM TABLETS safely and effectively. See full prescribing information for LOSARTAN POTASSIUM TABLETS. LOSARTAN POTASSIUM tablets USP, for oral use Rx Only Initial U.S. Approval: 1995
71335-1817-1	2024-01-30	These highlights do not include all the information needed to use LOSARTAN POTASSIUM TABLETS safely and effectively. See full prescribing information for LOSARTAN POTASSIUM TABLETS. LOSARTAN POTASSIUM tablets USP, for oral use Rx Only Initial U.S. Approval: 1995
71335-1817-2	2024-01-30	These highlights do not include all the information needed to use LOSARTAN POTASSIUM TABLETS safely and effectively. See full prescribing information for LOSARTAN POTASSIUM TABLETS. LOSARTAN POTASSIUM tablets USP, for oral use Rx Only Initial U.S. Approval: 1995
71335-1817-3	2024-01-30	These highlights do not include all the information needed to use LOSARTAN POTASSIUM TABLETS safely and effectively. See full prescribing information for LOSARTAN POTASSIUM TABLETS. LOSARTAN POTASSIUM tablets USP, for oral use Rx Only Initial U.S. Approval: 1995
71335-1817-4	2024-01-30	These highlights do not include all the information needed to use LOSARTAN POTASSIUM TABLETS safely and effectively. See full prescribing information for LOSARTAN POTASSIUM TABLETS. LOSARTAN POTASSIUM tablets USP, for oral use Rx Only Initial U.S. Approval: 1995
71335-1817-5	2024-01-30	These highlights do not include all the information needed to use LOSARTAN POTASSIUM TABLETS safely and effectively. See full prescribing information for LOSARTAN POTASSIUM TABLETS. LOSARTAN POTASSIUM tablets USP, for oral use Rx Only Initial U.S. Approval: 1995
71335-1817-6	2024-01-30	These highlights do not include all the information needed to use LOSARTAN POTASSIUM TABLETS safely and effectively. See full prescribing information for LOSARTAN POTASSIUM TABLETS. LOSARTAN POTASSIUM tablets USP, for oral use Rx Only Initial U.S. Approval: 1995
71335-1817-7	2024-01-30	These highlights do not include all the information needed to use LOSARTAN POTASSIUM TABLETS safely and effectively. See full prescribing information for LOSARTAN POTASSIUM TABLETS. LOSARTAN POTASSIUM tablets USP, for oral use Rx Only Initial U.S. Approval: 1995

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
71335-1817-1	Losartan potassium Tablets, 50 mg	30 in 1 BOTTLE	TABLET	30	101
71335-1817-2	Losartan potassium Tablets, 50 mg	90 in 1 BOTTLE	TABLET	90	101
71335-1817-3	Losartan potassium Tablets, 50 mg	60 in 1 BOTTLE	TABLET	60	101
71335-1817-4	Losartan potassium Tablets, 50 mg	120 in 1 BOTTLE	TABLET	120	101
71335-1817-5	Losartan potassium Tablets, 50 mg	100 in 1 BOTTLE	TABLET	100	101
71335-1817-6	Losartan potassium Tablets, 50 mg	180 in 1 BOTTLE	TABLET	180	101
71335-1817-7	Losartan potassium Tablets, 50 mg	10 in 1 BOTTLE	TABLET	10	101
71335-1817-8	Losartan potassium Tablets, 50 mg	7 in 1 BOTTLE	TABLET	7	101

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
71335-1817	LOSARTAN POTASSIUM TABLETS, 50 MG (LOSARTAN POTASSIUM) TABLET [BRYANT RANCH PREPACK]	100	Current NDC, Legacy NDC, 8 package rows	20220106_3d7ddcac-508d-459c-96c8-c62f9c0b5193.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 9 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Losartan potassium Tablets, 25 mg	LOSARTAN POTASSIUM	Bryant Ranch Prepack	7b8f5329-4fdb-4e1d-98b1-de1ca1b171c5	2025-11-03	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 201170 application number: ANDA201170
Losartan potassium Tablets, 100 mg	LOSARTAN POTASSIUM	Bryant Ranch Prepack	726002cf-2d95-4dac-b1f6-e7f92bb13496	2025-11-03	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 201170 application number: ANDA201170
Losartan potassium Tablets, 50 mg	LOSARTAN POTASSIUM	Bryant Ranch Prepack	d67926b0-c22b-4803-b55d-c98a81389449	2025-11-03	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 201170 application number: ANDA201170
Losartan potassium Tablets, 50 mg	LOSARTAN POTASSIUM	Bryant Ranch Prepack	3d7ddcac-508d-459c-96c8-c62f9c0b5193	2025-10-02	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 201170 application number: ANDA201170 ndc (package): 71335-1817-3 ndc (product): 71335-1817 ndc11 (package): 71335181703
Losartan potassium Tablets, 50 mg	LOSARTAN POTASSIUM	Bryant Ranch Prepack	eea03814-3fb5-4f85-8a4d-18e73057d880	2025-09-10	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 201170 application number: ANDA201170
Losartan potassium Tablets, 100 mg	LOSARTAN POTASSIUM	Bryant Ranch Prepack	04c4ba11-a9bd-4fed-bf14-14214f33f9c2	2025-09-04	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 201170 application number: ANDA201170
Losartan potassium Tablets, 25 mg	LOSARTAN POTASSIUM	Bryant Ranch Prepack	ee58207e-3913-4262-87ec-930bb4ecf07b	2025-09-04	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 201170 application number: ANDA201170
Losartan potassium Tablets, 100 mg	LOSARTAN POTASSIUM	Coupler LLC	2d1b03bb-2355-baac-e063-6294a90a9b40	2025-02-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 201170 application number: ANDA201170
Losartan potassium Tablets, 25 mg	LOSARTAN POTASSIUM	Jubilant Cadista Pharmaceuticals Inc.	1bf520a2-a50e-a6ae-0fdf-9be4e69729c0	2024-12-12	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 201170 application number: ANDA201170

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
3ST302B24A	LOSARTAN POTASSIUM	124750-99-8	LOSARTAN POTASSIUM

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
979492	losartan potassium 50 MG Oral Tablet	PSN	3d7ddcac-508d-459c-96c8-c62f9c0b5193	101
979492	losartan potassium 50 MG Oral Tablet	SCD	3d7ddcac-508d-459c-96c8-c62f9c0b5193	101
979492	Losartan K+ 50 MG Oral Tablet	SY	3d7ddcac-508d-459c-96c8-c62f9c0b5193	101
979492	Losartan Pot 50 MG Oral Tablet	SY	3d7ddcac-508d-459c-96c8-c62f9c0b5193	101

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
71335-1817-3	71335181703	60 TABLET in 1 BOTTLE (71335-1817-3)	60 tablet	2021-12-21	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Losartan potassium Tablets, 50 mg	Bryant Ranch Prepack	2025-10-02	HUMAN PRESCRIPTION DRUG LABEL	101